AbstractSpirocercosis is a common parasitic disease in dogs in tropical and mediterranean regions of the world caused by the nematode Spirocerca lupi. Some dogs with spirocercosis develop sialoadenosis, a condition identified by non‐inflammatory, painless, bilateral enlargement of the mandibular salivary glands. Development of sialoadenosis in dogs infected with S. lupi occurs as a consequence of neurological stimulation caused by larval migration and oesophageal parasitic nodule formation. This report describes the clinical signs, diagnosis, treatment and the treatment outcome of two dogs diagnosed with sialoadenosis caused by spirocercosis. Phenobarbital therapy is useful to control clinical signs shown by the dogs with sialoadenosis secondary to spirocercosis presented at an early stage of the disease. A more favourable disease outcome is possible when phenobarbital therapy is combined with anti‐parasitic medication effective against S. lupi.